Lung Cancer Treatment (NSCLC)
肺癌治疗
Duration
2-6 months depending on stage and treatment plan
Recovery
2-4 weeks from surgery, ongoing for chemotherapy/immunotherapy cycles
Savings
~80% vs US
Average savings compared to US prices
China is a global leader in lung cancer treatment, offering cutting-edge approaches including robotic-assisted minimally invasive surgery, targeted therapy (EGFR/ALK inhibitors), immunotherapy, and advanced radiation techniques. Chinese thoracic surgeons perform some of the highest volumes of lung cancer operations worldwide, resulting in exceptional outcomes. Treatment costs are 70-80% lower than in the US, including access to novel domestic immunotherapy drugs.
Comprehensive Staging
PET-CT, brain MRI, molecular profiling (EGFR, ALK, ROS1, PD-L1) determine cancer stage and treatment targets
Duration: 3-5 daysMultidisciplinary Treatment Plan
Tumor board of thoracic surgeons, oncologists, and radiation experts design personalized treatment strategy
Duration: 1-2 daysPrimary Treatment
Robotic lobectomy for early stage, or systemic therapy (targeted/immunotherapy/chemo) for advanced disease
Duration: 1-6 monthsAdjuvant Therapy & Surveillance
Post-surgical chemotherapy or immunotherapy maintenance with regular imaging follow-up
Duration: 6-12 months- Access to China-developed immunotherapy drugs at lower cost
- High-volume surgical centers with excellent survival outcomes
- Comprehensive molecular profiling guides precision treatment
- 70-80% cost savings compared to equivalent US treatment
- Surgery risks include bleeding, infection, and air leaks
- Chemotherapy side effects (nausea, fatigue, immune suppression)
- Immunotherapy can cause autoimmune complications
- Advanced disease may not respond to available treatments
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.